<p>We discuss the feasibility of using home OCT vs. a treat and extend approach in a clinical trial of faricimab in neovascular AMD with Dr. Kevin Blinder of the Retina Institute in Saint Louis, Mo and Profesor of Ophthalmology at Washington University School of Medicine.</p>

We discuss the feasibility of using home OCT vs. a treat and extend approach in a clinical trial of faricimab in neovascular AMD with Dr. Kevin Blinder of the Retina Institute in Saint Louis, Mo and Profesor of Ophthalmology at Washington University School of Medicine.

A Feasbility Evaluating the Use of Home OCT  for a Clinical Trial of Faricimab Treatment of nAMD

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

Share A Feasbility Evaluating the Use of Home OCT for a Clinical Trial of Faricimab Treatment of nAMD

Sign up to save your podcasts

A Feasbility Evaluating the Use of Home OCT for a Clinical Trial of Faricimab Treatment of nAMD

A Feasbility Evaluating the Use of Home OCT for a Clinical Trial of Faricimab Treatment of nAMD

More shows like Retina Synthesis

Straight From The Cutter's Mouth: A Retina Podcast